 OncoSec Medical Incorporated NASDAQ:ONCS the Company or OncoSec, a company developing late-stage intratumoral cancer immunotherapies, today announced changes to its Board of Directors the Board following the closing of the strategic investment by and partnership the CGPSirtex Transaction with Grand Decade Developments Limited, a wholly owned subsidiary of China Grand Pharmaceutical and Healthcare Holdings Limited CGP, and its U.S. affiliate, Sirtex Medical US Holdings, Inc. Sirtex. 